Synthetic calcitonin-gene-related peptides for lowering blood pr

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

2601225R, 424 95, A61K 3702, C07C10352

Patent

active

045308381

ABSTRACT:
CGRP (calcitonin-gene-related peptide) has the formula: ##STR1## A related peptide has the residue Lys instead of Glu in the 35-position. CGRP or this homolog or pharmaceutically acceptable salts thereof, dispersed in a pharmaceutically acceptable liquid or solid carrier, can be administered to mammals, including humans, to influence memory, mood and pain appreciation and to achieve a substantial lowering of blood pressure or gastric acid secretion over an extended period of time. They also may be administered to affect ingestion behavior, taste and sensory perception.

REFERENCES:
Amara et al., "Alternative RNA Processing . . . ", Nature, vol. 298, 15, Jul. 1982.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Synthetic calcitonin-gene-related peptides for lowering blood pr does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Synthetic calcitonin-gene-related peptides for lowering blood pr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synthetic calcitonin-gene-related peptides for lowering blood pr will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-634180

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.